Recombinant human parathyroid hormone
 |
| Clinical data | |
|---|---|
| Trade names | Preotact, Natpara |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a617013 |
| License data | |
| Routes of administration | Subcutaneous injection |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| DrugBank | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C408H674N126O126S2 |
| Molar mass | 9424.76 g·mol−1 |
Recombinant human parathyroid hormone, sold under the brand names Preotact and Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]
References
- ^ "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Archived from the original on 30 January 2015. Retrieved 30 January 2015.
- ^ "Natpara Approval History". drugs.com. Retrieved 30 January 2015.
External links
- "Parathyroid hormone". Drug Information Portal. U.S. National Library of Medicine.
 | This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |